- Wealth PMS (50L+)
On the 17-Dec-15 (Thursday), the US FDA issued a Warning Letter to Sun Pharmaceuticals. The letter was in relation to the inspection performed from 8-19 September, 2014, at the Pharmaceutical manufacturing facility, Halol-Baroda Highway, Halol, Gujarat.
Sun Pharmaceuticals confirmed the receipt of the US FDA Warning Letter on the 19-Dec-15 (Saturday) - after the markets had closed for the week. (refer here for the Original Copy